Azenta Net Income Over Time
| AZTA Stock | USD 36.80 0.24 0.66% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Azenta Performance and Azenta Correlation. Azenta |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Azenta. If investors know Azenta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Azenta listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 87.778 | Earnings Share (3.17) | Revenue Per Share | Quarterly Revenue Growth 0.041 | Return On Assets |
The market value of Azenta Inc is measured differently than its book value, which is the value of Azenta that is recorded on the company's balance sheet. Investors also form their own opinion of Azenta's value that differs from its market value or its book value, called intrinsic value, which is Azenta's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Azenta's market value can be influenced by many factors that don't directly affect Azenta's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Azenta's value and its price as these two are different measures arrived at by different means. Investors typically determine if Azenta is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Azenta's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare Azenta Inc and related stocks such as Akoya Biosciences, AtriCure, and ATRION Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AKYA | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (14.8 M) | (16.7 M) | (42.9 M) | (70.6 M) | (63.3 M) | (57 M) | (59.8 M) |
| ATRC | (3.6 M) | (5.5 M) | (7.5 M) | (11.5 M) | (16.2 M) | (27.2 M) | (33.3 M) | (26.9 M) | (21.1 M) | (35.2 M) | (48.2 M) | 50.2 M | (46.5 M) | (30.4 M) | (44.7 M) | (42.5 M) |
| ICUI | 3 M | 44.7 M | 41.3 M | 40.4 M | 26.3 M | 45 M | 63.1 M | 68.6 M | 28.8 M | 101 M | 86.9 M | 103.1 M | (74.3 M) | (29.7 M) | (117.7 M) | (111.8 M) |
| HAE | 18 M | 66.9 M | 38.8 M | 35.1 M | 16.9 M | (55.6 M) | (26.3 M) | 45.6 M | 55 M | 76.5 M | 79.5 M | 43.4 M | 115.4 M | 117.6 M | 135.2 M | 142 M |
| MMSI | (400 K) | 23 M | 19.7 M | 16.6 M | 23 M | 23.8 M | 20.1 M | 27.5 M | 42 M | 5.5 M | (9.8 M) | 48.5 M | 74.5 M | 94.4 M | 120.4 M | 126.4 M |
| ANGO | 343 K | (5.1 M) | (614 K) | 3.1 M | (3.3 M) | (44.5 M) | 7 M | 16.3 M | 61.3 M | (165.8 M) | (31.5 M) | (26.5 M) | (52.4 M) | (184.3 M) | (165.9 M) | (157.6 M) |
| ATR | 19.5 M | 183.7 M | 162.6 M | 172 M | 191.7 M | 199.3 M | 205.6 M | 220 M | 194.7 M | 242.2 M | 214 M | 244.1 M | 239.3 M | 284.5 M | 374.5 M | 393.3 M |
| NVST | 275.5 M | 275.5 M | 275.5 M | 275.5 M | 275.5 M | 275.5 M | 272 M | 301.1 M | 230.7 M | 217.6 M | 33.3 M | 263.5 M | 243.1 M | (100.2 M) | (1.1 B) | (1.1 B) |
| HOLX | 1.4 M | (73.6 M) | (1.2 B) | 17.3 M | 131.6 M | 330.8 M | 755.5 M | (111.3 M) | (40.2 M) | 1.1 B | 1.9 B | 1.3 B | 456 M | 789.5 M | 907.9 M | 953.3 M |
| COO | 35.2 M | 248.3 M | 296.2 M | 269.9 M | 203.5 M | 273.9 M | 372.9 M | 139.9 M | 466.7 M | 238.4 M | 2.9 B | 385.8 M | 294.2 M | 392.3 M | 451.1 M | 473.7 M |
| BLCO | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 710 M | 298 M | (17 M) | 182 M | 15 M | (260 M) | (317 M) | (301.1 M) |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 2 B | 2.1 B |
Azenta Inc and related stocks such as Akoya Biosciences, AtriCure, and ATRION Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Azenta Inc financial statement analysis. It represents the amount of money remaining after all of Azenta Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Azenta Inc | AZTA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 36.8
Check out Azenta Performance and Azenta Correlation. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Azenta technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.